Pharma Manufacturing And Automation

November 15, 2022 | USA

Pharma Manufacturing
Join over 300 senior representatives across two days of cutting-edge presentations on the biggest issues and opportunities in drug product manufacturing and digital transformation.

Spotlight

CD47 is a cell surface ‘don’t eat me’ signal that has been shown to be important in detection and evasion of cancer cells, inflammation, neuronal pruning and other path ophysiological processes. Blocking CD47 allows tumor cells to be recognized by phagocytes and this cell-cell interaction initiates a cascade of events resulting in tumor cell destruction. As such CD47 is an attractive target for the development of novel therapeutics.


OTHER PAST CONFERENCES

Pharma 2022

October 11-13, 2022 | France

Comprehensive frameworks for equitable access and accelerated digital transformations are soon to be realized. But progress is slowing, risking a return to the old model plagued by persistent health disparities.

20th International Conference on Pharmaceutical Medicine

October 19-21, 2022 | Greece

2022 is a special year. We will be celebrating the long-awaited return of the 20th ICPM since the last one in 2018. It will also be the first time that ICPM will be accessible both on-site and on-line, ensuring you can access the very latest science and research updates, from wherever you are.

WORLD VACCINE CONGRESS EUROPE 2022

October 11-14, 2022 | Spain

World Vaccine Congress remains the industry’s definitive vaccine industry event for major vaccine players and their respective senior level representatives

Transform your data management, informatics systems utilisation and R&D processes.

November 15-17, 2022 | USA

The global laboratory informatics market is forecast to reach $3.8bn by 2024, with the growth driven primarily by the enhanced importance of data analytics for drug discovery, increasing regulatory requirements and the greater utilization of automation in the lab.

Spotlight

CD47 is a cell surface ‘don’t eat me’ signal that has been shown to be important in detection and evasion of cancer cells, inflammation, neuronal pruning and other path ophysiological processes. Blocking CD47 allows tumor cells to be recognized by phagocytes and this cell-cell interaction initiates a cascade of events resulting in tumor cell destruction. As such CD47 is an attractive target for the development of novel therapeutics.

resources